XORTX Therapeutics Inc. Gains 100.63%
Fri, Oct 20, 2023 at 07:18 PM
XORTX Therapeutics Inc. (XRTX:NASDAQ) shot up at $0.64, representing a gain of 100.6%. On Fri, Oct 20, 2023, XRTX:NASDAQ hit a New 2-Week High of $0.64. The stock appeared on our News Catalysts scanner on Thu, Oct 12, 2023 at 10:16 AM in the 'SPLIT' category. From Fri, Oct 06, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Oct 20, 2023 at $0.84 with a volume of 91M+.
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 100.63%
- Golden Minerals Company (AUMN:NYSEMKT), 49.61%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 38.69%
- Nouveau Monde Graphite Inc. (NMG:NYSE), 36.63%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 36.11%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 35.32%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 34.84%
- Aravive, Inc. (ARAV:NASDAQ), 31.75%
- FLJ Group Limited (FLJ:NASDAQ), 31.05%
- Northann Corp. (NCL:NYSEMKT), 30.43%